Search - tctmd.com

Displaying 81 - 100 of 142

Sort: Relevancy | Date

Presentation TCT 2022

Bioprosthetic Valve Failure and Durability—Does TAVR Really Outperform SAVR?

Presenter: Michael Reardon

September 19, 2022

Presentation TCT 2022

Considerations of TAVR and SAVR by age in the US including a clinically relevant definition of Bioprosthetic Durability

Presenter: Evelio Rodriguez

September 18, 2022

News Conference News TCT 2022

Sizing Mismatch a Problem for Balloon-Expandable Valves in Small Annuli TAVI

Yael L. Maxwell

September 18, 2022

Presentation TCT 2022

TCT 322: National Trends in TAVR and SAVR for Patients with Severe Isolated Aortic Stenosis

Presenter: Toishi Sharma

September 17, 2022

News Conference News TCT 2022

TAVI Sees Rapid Growth for Severe AS Across Age Spectrum in US

Caitlin E. Cox

September 16, 2022

Presentation TCT 2022

TAVR vs SAVR – Case-based Risk Discussion, What Do I Need to Know?: Case-based Lifelong Management of Aortic Stenosis

Presenter: Michael Querijero

September 16, 2022

Presentation TCT 2021

Prosthetic Valve Selection and Implant Techniques for Prevention of PPM/High Residual Gradients Following SAVR, TAVR, or Valve-in-Valve

Presenter: David Wood

November 06, 2021

News Conference News TCT 2021

TAVI Edges Out Surgery in 2-Year Costs for Low-risk Patients: PARTNER 3

Yael L. Maxwell

November 05, 2021

Presentation TCT 2021

PARTNER 3: Two-Year Economic Outcomes From a Randomized Trial of TAVR vs. SAVR in Patients at Low Surgical Risk

Presenter: David Cohen

November 05, 2021

News Conference News TCT 2021

SURTAVI: Self-Expanding TAVI Valve Holds Up vs SAVR Through 5 Years

Todd Neale

November 05, 2021

Presentation TCT 2021

SURTAVI: Five-Year Results From a Randomized Trial of TAVR vs. SAVR in Patients at Intermediate Surgical Risk

Presenter: Nicolas Van Mieghem

November 05, 2021

Presentation TCT 2021

Case Presentation: 75-Year-Old With Severe AS And Proximal LAD Stenosis - TAVI Alone, TAVI Plus PCI or SAVR Plus CABG?

Presenter: Yousif Ahmad

November 04, 2021

Presentation TCT 2021

Case Presentation: 65-Year-Old With Severe AS And Bicuspid Valve - SAVR or TAVI?

Presenter: Karim Al-Azizi

November 04, 2021

Presentation TCT 2021

Bioprosthetic Valve Failure: Redo SAVR or ViV TAVR?

Presenter: Kendra Grubb

November 04, 2021

News Conference News TCT 2021

Fracture Improves Gradients in ViV TAVI, but Ideal Timing Still Unknown

Michael O'Riordan

October 07, 2021

News Conference News TCT 2020

While Rare, Surgical Removal of TAVR Carries Risks: Global EXPLANT-TAVR Registry

L.A. McKeown

October 21, 2020

News Conference News TCT 2020

Encouraging Results Seen for TAVR in Failed Surgical or TAVR Valves

Todd Neale

October 17, 2020

News Conference News TCT 2020

Acurate Neo Fails to Match Results of CoreValve Evolut: SCOPE 2

Michael O'Riordan

October 15, 2020

News Conference News TCT 2020

Valve Disease Plus COVID-19 Often a Lethal Combination, Registry Shows

Caitlin E. Cox

October 14, 2020

News Conference News TCT 2019

TAVR Improves Health Status Over Surgery in Low-Risk Patients at 1 Year: PARTNER 3

Yael L. Maxwell

September 29, 2019

Advertisement

Bioprosthetic Valve Failure and Durability—Does TAVR Really Outperform SAVR?

Considerations of TAVR and SAVR by age in the US including a clinically relevant definition of Bioprosthetic Durability

Sizing Mismatch a Problem for Balloon-Expandable Valves in Small Annuli TAVI

TCT 322: National Trends in TAVR and SAVR for Patients with Severe Isolated Aortic Stenosis

TAVI Sees Rapid Growth for Severe AS Across Age Spectrum in US

TAVR vs SAVR – Case-based Risk Discussion, What Do I Need to Know?: Case-based Lifelong Management of Aortic Stenosis

Prosthetic Valve Selection and Implant Techniques for Prevention of PPM/High Residual Gradients Following SAVR, TAVR, or Valve-in-Valve

TAVI Edges Out Surgery in 2-Year Costs for Low-risk Patients: PARTNER 3

PARTNER 3: Two-Year Economic Outcomes From a Randomized Trial of TAVR vs. SAVR in Patients at Low Surgical Risk

SURTAVI: Self-Expanding TAVI Valve Holds Up vs SAVR Through 5 Years

SURTAVI: Five-Year Results From a Randomized Trial of TAVR vs. SAVR in Patients at Intermediate Surgical Risk

Case Presentation: 75-Year-Old With Severe AS And Proximal LAD Stenosis - TAVI Alone, TAVI Plus PCI or SAVR Plus CABG?

Case Presentation: 65-Year-Old With Severe AS And Bicuspid Valve - SAVR or TAVI?

Bioprosthetic Valve Failure: Redo SAVR or ViV TAVR?

Fracture Improves Gradients in ViV TAVI, but Ideal Timing Still Unknown

While Rare, Surgical Removal of TAVR Carries Risks: Global EXPLANT-TAVR Registry

Encouraging Results Seen for TAVR in Failed Surgical or TAVR Valves

Acurate Neo Fails to Match Results of CoreValve Evolut: SCOPE 2

Valve Disease Plus COVID-19 Often a Lethal Combination, Registry Shows

TAVR Improves Health Status Over Surgery in Low-Risk Patients at 1 Year: PARTNER 3

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content